Last reviewed · How we verify
NCT05607888: Sinonasal_Tu
Prospective Study of Sinonasal and Skull-base Tumours Management
trial in Nasal Neoplasm in 120 participants. Currently enrolling.
1 January 2027
Quick facts
| Lead sponsor | University Medical Centre Ljubljana |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 120 |
| Start date | 1 January 2022 |
| Primary completion | 1 January 2027 |
| Estimated completion | 31 December 2027 |
| Sites | 1 location across Slovenia |
Conditions studied
- Nasal Neoplasm — all drugs for Nasal Neoplasm →
- Nasal Neoplasm Benign — all drugs for Nasal Neoplasm Benign →
- Skull Base Neoplasms — all drugs for Skull Base Neoplasms →
- Skull Base Osteomyelitis — all drugs for Skull Base Osteomyelitis →
Sponsor
University Medical Centre Ljubljana
Who can join
Eligibility, any sex, with Nasal Neoplasm or Nasal Neoplasm Benign. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This observational prospective clinical study aims to describe the epidemiology, management and outcome of patients with sinonasal and skull-base pathology (tumours and diseases with malignant clinical characteristics) in a tertiary otorhinolaryngology referral centre. The main questions it aims to answer are: * what is the caseload of patients with the included pathology in our centre * what are the results of management of these cases * what are the epidemiological characteristics of included patients * what is the quality of life of included patients.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
A Multidisciplinary Skull Base Board for Tumour and Non-Tumour Diseases: Initial Experiences.
Urbančič J, Battelino S, Bošnjak R, Felbabić T, et al · · 2024 · cited 3× · PMID 38248783 · DOI 10.3390/jpm14010082 -
Quality of life in Slovenian patients with skull base tumours: cross-cultural adaptation and validation of a Slovenian skull base inventory.
Vozel D, Urbancic J, Battelino S, Urbancic NB, et al · · 2026 · PMID 41560283 · DOI 10.2478/raon-2026-0007
Verify or expand the search:
- PubMed search for NCT05607888
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other University Medical Centre Ljubljana trials
Trials by the same sponsor.
- NCT07466472 — Image-Guided Central Catheter Insertion With Concurrent Assessment of Vascular Wall Integrity · not yet recruiting
- NCT07446244 — Catheter Ablation of Advanced Forms of Atrial Fibrillation · NA · enrolling by invitation
- NCT07109076 — Effect of Immediate Skin-to-Skin Contact on Neonatal Heart Rate Variability After Cesarean Secton · NA · recruiting
- NCT07354880 — Effect of Tirzepatide on Cardiovascular and Metabolic Parameters in Obese Adult Patients With Congenital Heart Disease · Phase 4 · not yet recruiting
- NCT07496736 — Post-exposure Influenza Prophylaxis in a Hospital Setting · Phase 3 · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05607888 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University Medical Centre Ljubljana
- Last refreshed: 25 September 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05607888.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing